AXT, Inc. (AXTI), a producer of compound semiconductor substrates used in high‑speed data, 5G, and optoelectronic applications, saw its shares fall more than 6% today. The pullback comes just days after the stock hit a new 12‑month high, as investors digested mixed fourth‑quarter and full‑year 2025 results, ongoing losses, and heavy insider selling against a backdrop of very strong year‑to‑date gains.
Key Takeaways
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date.
Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Although non‑GAAP EPS of –$0.05 beat expectations by a penny and gross margins improved versus the prior year, full‑year 2025 revenue declined to $88.3 million from $99.4 million, underscoring that growth has not yet re‑accelerated.
The recent disclosure that Director Jesse Chen and other insiders sold nearly 100,000 shares between March 2–13, generating more than $4.3 million, has fueled profit‑taking and raised questions about valuation after the stock’s parabolic run.
Management remains optimistic about 2026, pointing to a large backlog and rising demand for indium phosphide substrates in AI data‑center interconnects, but investors are weighing that long‑term opportunity against near‑term export‑permit constraints, continued losses, and a rich share price.
On a day when a high‑beta semiconductor name like AXTI swings more than 6% after a run of double‑digit moves, many traders turn to AI‑powered tools to put the action in context. Tickeron‑style AI engines can automatically flag that today’s decline is occurring shortly after earnings, a 52‑week high, and notable insider sales, then compare the magnitude of the move with historical volatility for AXTI and peers. By scanning for abnormal volume, options activity, and breaks of key technical levels such as the 50‑day moving average, AI models can highlight whether the selloff looks like a routine consolidation after a parabolic run or the start of a deeper trend change. For short‑term traders and risk‑focused investors, AI‑driven screeners, pattern‑recognition tools, and real‑time risk dashboards offer a more objective framework than gut feel when deciding whether to buy the dip, take profits, or stand aside.
Fundamentally, the latest quarter underscored both progress and ongoing challenges. In Q4 2025, AXT reported revenue of $23.0 million, down from $28.0 million in Q3 2025 and $25.1 million in Q4 2024, missing analyst expectations of about $24.24 million and reflecting weaker demand and export‑permit limitations. GAAP gross margin improved to 20.9%, up from 17.6% a year earlier but slightly below the prior quarter, while non‑GAAP gross margin of 21.5% also ticked higher year over year. The company posted a GAAP net loss of approximately $3.5 million (–$0.08 per share), a modest improvement versus the –$0.12 per share loss a year earlier but wider than the –$0.04 per share loss in Q3. On a non‑GAAP basis, Q4 net loss was about –$0.05 per share, beating consensus by a cent.
For the full year 2025, revenue fell to $88.3 million from $99.4 million in 2024, and AXT remained solidly loss‑making, with a GAAP net loss of roughly $21 million (–$0.48 per share) and a non‑GAAP net loss of about $18 million (–$0.41 per share). Management attributed much of the pressure to export‑license constraints, particularly on shipments tied to China, and to a slower‑than‑expected recovery in certain end markets. At the same time, executives struck an upbeat tone on the outlook, citing a significant backlog — including more than $60 million in indium phosphide orders — and anticipating revenue growth in Q1 2026 as AI‑driven data‑center demand ramps.
Valuation and positioning, however, left little room for disappointment. AXTI has been one of 2026’s standout semiconductor performers, with shares more than doubling year‑to‑date and recently touching a 52‑week high around $47.07. MarketBeat and other outlets noted that the stock was trading well above its 50‑ and 200‑day moving averages, with a 50‑day average near $28, highlighting how far and how fast the rally had extended. In that context, even a modest revenue miss and another quarterly loss were enough to prompt a wave of profit‑taking, particularly as traders reacted to a string of insider sales disclosed in mid‑March. Director Jesse Chen’s sale of about 99,800 shares between March 2 and March 13 — including 8,083 shares at $50.25 — crystallized millions in gains and signaled to some investors that management believes the near‑term risk‑reward has become less favorable after the run‑up.
Broader industry dynamics add another layer to the story. On the positive side, both the indium phosphide and gallium arsenide substrate markets are expected to grow at high single‑ to low double‑digit CAGRs through the early 2030s, supported by rising demand for high‑speed, high‑efficiency components in AI data centers, 5G infrastructure, photonics, and advanced RF systems. These trends underpin the long‑term bull case that AXT is a key enabler of next‑generation networking and optoelectronics. On the negative side, export‑license timing, capital‑intensive crystal‑growth expansions, and the need to secure high‑purity raw materials create volatility in both volumes and margins, while any macro slowdown or capex pause in data‑center build‑outs could hit orders hard.
Looking ahead, the main question for investors is whether today’s roughly 6% pullback marks a healthy consolidation after a spectacular run or the start of a more extended re‑rating as expectations normalize. Bulls will emphasize that AXT’s core thesis remains intact: it occupies a strategically important niche in compound semiconductors, has a sizable backlog tied to AI infrastructure, and continues to improve gross margins over time. Bears will point to declining 2025 revenue, persistent losses, export‑permit risk, and heavy insider selling as reasons to be cautious after such a rapid appreciation in the share price. Until future quarters show a clear inflection in top‑line growth and sustainable profitability, days like today — with a mid‑single‑digit decline on otherwise “mixed but improving” results — are likely to remain part of the AXTI narrative.
Tickeron AI Perspective
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where AXTI advanced for three days, in of 278 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on June 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXTI as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for AXTI turned negative on May 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .
AXTI moved below its 50-day moving average on June 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AXTI crossed bearishly below the 50-day moving average on June 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXTI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for AXTI entered a downward trend on July 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 47, placing this stock slightly worse than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (22.272) is normal, around the industry mean (12.514). AXTI has a moderately low P/E Ratio (0.000) as compared to the industry average of (117.123). AXTI's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.237). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (44.643) is also within normal values, averaging (128.191).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufactures of high-performance compound semiconductor substrates
Industry ElectronicProductionEquipment